Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With NRG1 Gene Fusion Advanced Solid Tumors
Conditions: Non-Small Cell Lung Cancer; Pancreatic Cancer; Locally Advanced Solid Tumor; Metastatic Solid Tumor Interventions: Drug: HMBD-001; Drug: Docetaxel; Drug: Nab-paclitaxel; Drug: Gemcitabine Sponsor: Hummingbird Bioscience Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Genetics | Research | Study | Taxotere